Literature DB >> 30211194

Two novel mutations in parE among Shigella flexneri isolated from Jiangsu Province of China, 2016.

Cun Xue1, Jinchi Cai2, Haiquan Kang3, Ying Chen1, Kaixuan Wang1, Huimin Qian4, Changjun Bao4, Na Li1, Zhen Guo1, Zheng Zhang1, Jing Wang5, Ping Ma1,3, Bing Gu1,3.   

Abstract

BACKGROUND: The study was conducted to assess the resistance capacity of quinolone against Shigella flexneri, and to investigate the involved quinolone resistance mechanism. The data were collected from Jiangsu Province, China in 2016.
METHODS: The number of 81 S. flexneri was obtained from 12 cities in Jiangsu Province of China during 2016. Slide agglutination was taken for serotyping, and susceptibility test was identified by the disc diffusion method. PCR aimed to amplify the quinolone resistance-determining region (QRDR) genes and screen for plasmid-mediated quinolone resistance (PMQR) determinants. Chromosomal mutation was confirmed by sequencing and Blast comparison.
RESULTS: 2a was the commonest serotype, accounting for 40.7% (33/81) of the 81 S. flexneri. 70.4% (57/81) isolates expressed resistance against nalidixic acid, and the resistance against ciprofloxacin even reached up to a high proportion of 58.0% (47/81). A total of 8 point mutations were identified, including 2 novel mutations discovered in parE (Ser458Leu and Gly408Asp). The common mutation Ser83Leu in gyrA was still the most prevalent here with a percentage of 70.4% (57/81), followed by the approximate mutation of 69.1% (56/81) in parC (Ser80Ile) and His211Tyr in gyrA. Meanwhile, 35.8% (29/81) isolates were confirmed with mutation of Gln517Arg in gyrB. In addition, qnrS positive isolates occupied a proportion of 7.4% (6/81), but only 1 strain was observed with aac(6')-Ib-cr. All PMQR positive isolates were resistant to nalidixic acid. However, 5 of them didn't stay susceptible to ciprofloxacin any more.
CONCLUSIONS: This is the first time that a study researches the occurrence of mutations in parE among S. flexneri, Ser458Leu and Gly408Asp included. The study indicates that the high resistance to fluoroquinolone remains a serious problem in Jiangsu, China. Thus, the prevention and control of current infection urge for a comprehensive and systematic surveillance based on persistent surveys.

Entities:  

Keywords:  Jiangsu; S. flexneri; parE; plasmid-mediated quinolone resistance (PMQR); resistance

Year:  2018        PMID: 30211194      PMCID: PMC6123205          DOI: 10.21037/atm.2018.07.11

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  42 in total

Review 1.  Molecular mechanisms of antibacterial multidrug resistance.

Authors:  Michael N Alekshun; Stuart B Levy
Journal:  Cell       Date:  2007-03-23       Impact factor: 41.582

2.  Structural Insights into the Fluoroquinolone Resistance Mechanism of Shigella flexneri DNA Gyrase and Topoisomerase IV.

Authors:  Jayashree Ramana
Journal:  Microb Drug Resist       Date:  2016-02-09       Impact factor: 3.431

3.  Quinolone resistance-determining region mutations and the plasmid-mediated quinolone resistance gene qnrS played important roles in decreased susceptibility to fluoroquinolones among Shigella isolates in southeast China between 1998 and 2013.

Authors:  Xiao-Ying Pu; Jing-Cao Pan; Wei Zhang; Wei Zheng; Hao-Qiu Wang; Ya-Ming Gu
Journal:  Int J Antimicrob Agents       Date:  2014-12-22       Impact factor: 5.283

4.  Shift in serotype distribution of Shigella species in China, 2003-2013.

Authors:  S Qiu; X Xu; C Yang; J Wang; B Liang; P Li; H Li; S Yi; H Liu; X Cui; Z Wu; J Xie; L Jia; L Wang; R Hao; H Jin; Y Wang; Y Sun; H Song
Journal:  Clin Microbiol Infect       Date:  2014-11-07       Impact factor: 8.067

5.  Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Authors:  K L Kotloff; J P Winickoff; B Ivanoff; J D Clemens; D L Swerdlow; P J Sansonetti; G K Adak; M M Levine
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

6.  qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin.

Authors:  L M Cavaco; H Hasman; S Xia; F M Aarestrup
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

7.  Prevalence and antimicrobial resistance of Shigella flexneri serotype 2 variant in China.

Authors:  Xianyan Cui; Jian Wang; Chaojie Yang; Beibei Liang; Qiuxia Ma; Shengjie Yi; Hao Li; Hongbo Liu; Peng Li; Zhihao Wu; Jing Xie; Leili Jia; Rongzhang Hao; Ligui Wang; Yuejin Hua; Shaofu Qiu; Hongbin Song
Journal:  Front Microbiol       Date:  2015-05-07       Impact factor: 5.640

8.  Surveillance of antimicrobial susceptibility patterns among Shigella species isolated in China during the 7-year period of 2005-2011.

Authors:  Haifei Yang; Guosheng Chen; Yulin Zhu; Yanyan Liu; Jun Cheng; Lifen Hu; Ying Ye; Jiabin Li
Journal:  Ann Lab Med       Date:  2013-02-21       Impact factor: 3.464

9.  Shigella Antimicrobial Drug Resistance Mechanisms, 2004-2014.

Authors:  Magdalena Nüesch-Inderbinen; Nicole Heini; Katrin Zurfluh; Denise Althaus; Herbert Hächler; Roger Stephan
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883

10.  Molecular characterization and analysis of high-level multidrug-resistance of Shigella flexneri serotype 4s strains from China.

Authors:  Chaojie Yang; Peng Li; Xiujuan Zhang; Qiuxia Ma; Xianyan Cui; Hao Li; Hongbo Liu; Jian Wang; Jing Xie; Fuli Wu; Chunyu Sheng; Xinying Du; Lihua Qi; Wenli Su; Leili Jia; Xuebin Xu; Jiayong Zhao; Shengli Xia; Na Zhou; Hui Ma; Shaofu Qiu; Hongbin Song
Journal:  Sci Rep       Date:  2016-07-04       Impact factor: 4.379

View more
  1 in total

1.  Shigella: Antibiotic-Resistance Mechanisms And New Horizons For Treatment.

Authors:  Reza Ranjbar; Abbas Farahani
Journal:  Infect Drug Resist       Date:  2019-10-07       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.